The goal of Dr. Wu's research is to develop new strategies to prevent CP. Her research has been funded by NIH, Thrasher Research Fund, CP Alliance, CP International Research Foundation and others. Dr. Wu has been the recipient of several teaching awards at UCSF. She is on the Editorial Boards of Pediatric Neurology and Journal of Child Neurology, and served as an elected Council Member for the Society for Pediatric Research. Dr. Wu has published over 77 papers, including in high impact journals such as JAMA, NEJM, and Pediatrics. She authors UpToDate chapters on hypoxic-ischemic encephalopathy, and has written several review chapters on perinatal stroke and cerebral palsy. Dr. Dr. Wu has studied erythropoietin as a novel neuroprotective therapy for newborn infants with hypoxic-ischemic brain injury. She was the PI of NEAT and NEAT O (Phase I and Phase II studies), and is currently the PI of a large NIH-funded multi-center Phase III clinical trial (HEAL) studying erythropoietin in this population (www.heal-trial.org).